Previous Page  3 / 10 Next Page
Information
Show Menu
Previous Page 3 / 10 Next Page
Page Background

Page 20

Volume 02

Stem Cells 2019 & Pediatrics Congress 2019

November 06-07, 2019

Journal of Clinical Genetics and Genomics

November 06-07, 2019 | Tokyo, Japan

STEM CELLS AND REGENERATIVE MEDICINE

PEDIATRICS AND CHILD CARE

International Conference on

2

nd

World Congress on

&

J Clin Gen Genomics, Volume 02

Mesenchymal stem cells in transplantation: Effect of immunosuppressive drugs

Magdalena Krulova

Charles University, Czech Republic

M

esenchymal stem cells (MSCs) due to their immunosuppressive and regenerative properties offer a great potential for the

application in the clinic, including the transplantation medicine. It was documented that co-transplantation of grafted tissue

with MSCs attenuated rejection reaction. In the therapy of various pathological conditions, applied MSCs interact with different

drugs, which can influence their action. And vice versa, MSCs can modulate the effect of such treatment. Our results demonstrated

that the therapy combining immunosuppressive agents with MSCs favourably influenced immune balance, attenuated the adverse

effects of immunosuppressive drugs and prolonged the survival of transplanted allogeneic cells. Mechanisms involved in the

anti-inflammatory effect of the interactions between MSCs, immunosuppressive drugs and the immune system included switch

in the macrophage phenotype, as well as changes in the subpopulations. As a result, the inflammation was attenuated and a

regenerative environment promoted in the presence of MSCs. We also documented that MSCs isolated from different sources are

differently affected by the immunosuppressive drug treatment. All these findings should be taken into accounts before preparing

strategies combining the use of immunosuppressive drugs and MSCs or the administration of MSCs into an immunosuppressed

organism.

Biography

The aim of research of Krulova is to characterize the molecular and cellular mechanisms of specific immunity which can be consequently

applied in targeted immunoregulation for both the experimental work and the clinical practice. In recent years, her research has focused

on the study of mesenchymal stem cells and Sertoli cells, their characterization, possibilities of differentiation, interaction with cells of

the immune system and their use in transplant medicine.

krulova@natur.cuni.cz